Estimating the “First in human” dose – a revisit with particular emphasis on oncology drugs
نویسنده
چکیده
The initial dose selection is one of the important steps for any investigative new drug (IND) entering the first clinical study in humans. In this mini review, we will discuss the no observed adverse effect level (NOAEL) and the minimum anticipated biological effect level (MABEL) approaches for the estimation of the first in human (FIH) dose. Particular attention will be placed on the development of the FIH dose for oncology drugs.
منابع مشابه
Radio-adaptive doses effect on HT29 and MRC5 cell lines: comparison in hypo and hyper fractionation regime
Background: The exposure of cell lines to low-dose irradiation leads to changes at molecular level, which may induce adaptive response. We examined radio-adaptive doses effect on human colorectal adenocarcinoma cell line (HT29) and human fetal fibroblasts (MRC5) cell line followed by hyper and hypo fractionation regimes, with main purpose to decrease cell viability in HT29, and at the same time...
متن کاملThe Comparison 2D and 3D Treatment Planning in Breast Cancer Radiotherapy with Emphasis on Dose Homogeneity and Lung Dose
Introduction: Breast conserving radiotherapy is one of the most common procedures performed in any radiation oncology department. A tangential parallel-opposed pair is usually used for this purpose. This technique is performed using 2D or 3D treatment planning systems. The aim of this study was to compare 2D treatment planning with 3D treatment planning in tangential irradiation in breast conse...
متن کاملMonoclonal Antibodies as Therapeutic Agents: Advances and Challenges
Despite the major advances in conventional forms of treatment (i.e. surgical techniques, radiotherapy and chemotherapy) and improved survival rates, cancer is still the second leading cause of death in developing countries. One major limitation of cytotoxic drugs and radiation in the treatment of cancer patients is their inability to discriminate between malignant and normal tissues. This in tu...
متن کاملDose-dense paclitaxel-containing adjuvant therapy for breast cancer.
The use of dose-dense therapy is one approach to overcoming the "resistance" of malignant cells to adjuvant therapy caused by inadequate drug exposure. In this approach, active drugs are delivered sequentially at their "ideal" dose level separated by short intertreatment intervals. Thus, dose intensification is achieved by means of rapidly recycled treatments rather than by dramatic dose escala...
متن کاملA Study of Dashtaki`s View on the Appearance of Human Being with an Emphasis on the first verse of the chapter al-Insan
Hakim Dashtaki has viewed human being as spacio-temporal being and future etrnal but not past eternal. He has proved the view by relying on the verse: Hath there come Upon man (ever) any period of time in which he was a thing unremembered? Ibn Arabi, however, views human being as both past eternal and future eternal. The article has intended to study some commenators` opinions of the verse and ...
متن کامل